Maipu Medical: Supervisory Board\'s Review Opinions on the 2023 Restricted Stock Incentive Plan Granted Part of the First Vesting Period Ownership List for the First Time
Maipu Medical: Announcement on the Abolition of Restricted Stocks Partially Granted in the 2023 Restricted Stock Incentive Plan but not yet owned
Maipu Medical: Announcement on the 2023 Restricted Stock Incentive Plan for the First Time Granting Part of the Achievement of Vesting Conditions for the First Vesting Period
Maipu Medical: Beijing Zhonglun (Guangzhou) Law Firm\'s Legal Opinion on the Company\'s 2023 Restricted Stock Incentive Plan for the First Time Granting of Part of the First Vesting Period, and the Cancellation of Some Restricted Shares Granted but Not Owned
Maipu Medical: Announcement on the cancellation of the pledge of some shares of the company\'s actual controller and controlling shareholder
Medprin Regenerative Medical Technologies: Announcement on partial share pledges by the actual controllers and major shareholders of the company.
Medprin Regenerative Medical Technologies: Notice on the Listing of Partly Restricted Shares Prior to Initial Public Offering
Medprin Regenerative Medical Technologies: Self-inspection report on insider information of the 2024 Restricted Stock Incentive Plan and the buying and selling of company stocks by the first recipients of incentives.
Medprin Regenerative Medical Technologies: List of first-time incentive recipients for the 2024 restricted stock incentive plan (grant date).
Medprin Regenerative Medical Technologies: Guangzhou Maitai Regenerative Medical Technology Co., Ltd.'s restricted stock incentive plan for 2024.
Medprin Regenerative Medical Technologies: Announcement on the first grant of restricted stocks to the beneficiaries of the 2024 restricted stock incentive plan.
Medprin Regenerative Medical Technologies: Legal opinion of Zhong Lun (Guangzhou) Law Firm regarding the first grant of Guangzhou HBMEDICINE Technology Co., Ltd.'s 2024 restricted stock incentive plan.
Medprin Regenerative Medical Technologies: The Supervisory Board's verification opinion and public announcement on the initial grant list of the restricted stock incentive plan for the company in 2024.
Medprin Regenerative Medical Technologies: 2024 Restricted Stock Incentive Plan Self-Inspection Form
Medprin Regenerative Medical Technologies: Legal opinion of Zhonglun (Guangzhou) Law Firm on the adjustment of the grant price and reserved restricted stocks of Guangzhou MP Biomedicals Technology Co., Ltd.'s 2023 restricted stock incentive plan.
Medprin Regenerative Medical Technologies: List of first-time incentive recipients for the 2024 restricted stock incentive plan.
Medprin Regenerative Medical Technologies: Proposed 2024 Restricted Stock Incentive Plan for Guangzhou MP Biomedical Technology Co., Ltd.
Medprin Regenerative Medical Technologies: Legal opinion regarding the 2024 Restricted Stock Incentive Plan of Guangzhou Maipu Regenerative Medical Technology Co., Ltd. by Zhong Lun (Guangzhou) Law Firm, Peking.
Medprin Regenerative Medical Technologies: Announcement on the Adjustment of the Grant Price of Restricted Stock Incentive Plan for 2023.
Medprin Regenerative Medical Technologies: Announcement about reserving restricted stocks for the recipients of the 2023 restricted stock incentive plan.
No Data
No Data